BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23263503)

  • 1. Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells.
    Milward K; Issa F; Hester J; Figueroa-Tentori D; Madrigal A; Wood KJ
    Transplantation; 2013 Jan; 95(1):85-93. PubMed ID: 23263503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive Characteristics of Umbilical Cord Blood-derived Regulatory T Cells After Ex Vivo Expansion on Autologous and Allogeneic T Effectors and Various Lymphoblastic Cells.
    Vanichapol T; Pongsakul N; Srisala S; Apiwattanakul N; Chutipongtanate S; Hongeng S
    J Immunother; 2019 May; 42(4):110-118. PubMed ID: 30921263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4(+)CD25 (+) T cells.
    Lin SJ; Lu CH; Yan DC; Lee PT; Hsiao HS; Kuo ML
    Immunol Res; 2014 Oct; 60(1):105-11. PubMed ID: 24515612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.
    Hippen KL; Harker-Murray P; Porter SB; Merkel SC; Londer A; Taylor DK; Bina M; Panoskaltsis-Mortari A; Rubinstein P; Van Rooijen N; Golovina TN; Suhoski MM; Miller JS; Wagner JE; June CH; Riley JL; Blazar BR
    Blood; 2008 Oct; 112(7):2847-57. PubMed ID: 18645038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of intracellular galectin-1-expressing lymphocytes in umbilical cord blood in comparison with adult peripheral blood.
    Kollár S; Sándor N; Molvarec A; Stenczer B; Rigó J; Tulassay T; Vásárhelyi B; Toldi G
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1608-13. PubMed ID: 22609846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs.
    Porter SB; Liu B; Rogosheske J; Levine BL; June CH; Kohl VK; Wagner JE; Miller JS; Blazar BR
    Transplantation; 2006 Jul; 82(1):23-9. PubMed ID: 16861937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation.
    Robinson KL; Ayello J; Hughes R; van de Ven C; Issitt L; Kurtzberg J; Cairo MS
    Exp Hematol; 2002 Mar; 30(3):245-51. PubMed ID: 11882362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic cord blood regulatory T cells can resolve lung inflammation.
    Lyu MA; Huang M; Zeng K; Li L; Khoury JD; Nishimoto M; Ma H; Sadeghi T; Mukherjee S; Slutsky AS; Flowers CR; Parmar S
    Cytotherapy; 2023 Mar; 25(3):245-253. PubMed ID: 36437190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
    Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
    J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation.
    Encabo A; Solves P; Carbonell-Uberos F; Miñana MD
    Transfusion; 2007 Feb; 47(2):272-9. PubMed ID: 17302774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third-party regulatory T cells prevent murine acute graft-versus-host disease.
    Lim JY; Im KI; Song Y; Kim N; Nam YS; Jeon YW; Cho SG
    Korean J Intern Med; 2018 Sep; 33(5):980-989. PubMed ID: 29050459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease.
    Theil A; Tuve S; Oelschlägel U; Maiwald A; Döhler D; Oßmann D; Zenkel A; Wilhelm C; Middeke JM; Shayegi N; Trautmann-Grill K; von Bonin M; Platzbecker U; Ehninger G; Bonifacio E; Bornhäuser M
    Cytotherapy; 2015 Apr; 17(4):473-86. PubMed ID: 25573333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease.
    Parmar S; Liu X; Tung SS; Robinson SN; Rodriguez G; Cooper LJ; Yang H; Shah N; Yang H; Konopleva M; Molldrem JJ; Garcia-Manero G; Najjar A; Yvon E; McNiece I; Rezvani K; Savoldo B; Bollard CM; Shpall EJ
    Cytotherapy; 2014 Jan; 16(1):90-100. PubMed ID: 24480547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.
    St John LS; Wan L; He H; Garber HR; Clise-Dwyer K; Alatrash G; Rezvani K; Shpall EJ; Bollard CM; Ma Q; Molldrem JJ
    Cytotherapy; 2016 Aug; 18(8):995-1001. PubMed ID: 27378343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxp3 expression in induced T regulatory cells derived from human umbilical cord blood vs. adult peripheral blood.
    Do JS; Zhong F; Huang AY; Van't Hof WJ; Finney M; Laughlin MJ
    Bone Marrow Transplant; 2018 Dec; 53(12):1568-1577. PubMed ID: 29743573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution.
    Brown JA; Boussiotis VA
    Clin Immunol; 2008 Jun; 127(3):286-97. PubMed ID: 18395491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter.
    Mayer E; Bannert C; Gruber S; Klunker S; Spittler A; Akdis CA; Szépfalusi Z; Eiwegger T
    PLoS One; 2012; 7(1):e29355. PubMed ID: 22272233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic Cells Differentiated from Human Umbilical Cord Blood-Derived Monocytes Exhibit Tolerogenic Characteristics.
    Kim SK; Yun CH; Han SH
    Stem Cells Dev; 2015 Dec; 24(23):2796-807. PubMed ID: 26203805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.